+23.5%
GSK vs VSH
+112.8%
-89.3%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | +0.7% | -0.5% | +0.2% |
| 7D | -3.6% | +3.5% | -7.1% | -3.5% |
| 30D | -5.9% | -4.4% | -1.5% | -6.0% |
| 3M | -4.3% | -45.8% | +41.6% | -4.8% |
| 6M | -10.8% | +90.1% | -100.9% | -16.4% |
| YTD | +1.8% | +120.3% | -118.5% | -6.4% |
| 1Y | +23.5% | +112.2% | -88.8% | +12.1% |
| All | +23.5% | +112.8% | -89.3% | +12.1% |
Cumulative growth
Daily Returns
Daily percentage return beside VSH.
Daily Out/Under-Performance
Portfolio return minus VSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling